NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001228

Registered date:02/07/2008

Neuroimaging study for late-life depression

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedlate-life depression
Date of first enrollment2008/07/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)PET, MRI, Neuropsychology PET, MRI, Neuropsychology

Outcome(s)

Primary OutcomeFindings of the comparison between depression patients and age- and gender-matched normal controls with regard to the following factors: PET study (serotonin-transporter binding, amyloid deposition, and glucose metabolism) Structural MRI Neuropsychology
Secondary OutcomeRelationships between clinical symptoms or disease course and neuroimaging or neuropsychological tests

Key inclusion & exclusion criteria

Age minimum60years-old
Age maximum84years-old
GenderMale and Female
Include criteria
Exclude criteriaExclusion criteria for patients 1) Serious suicidal ideation or behavior 2) Mini-mental state examination score at screening, <=23 points 3) Co-morbid other psychiatric disorders including drug dependence 4) Existence of brain organic disease, including current or past history of cerebrovascular disease, Parkinson's disease, and other related disorders 5) Existence of serious medical illnesses 6) Subjects who are judged by researchers as not suitable for participation in the study

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail
Affiliation National Institute of Radiological Sciences Molecular Imaging Center
scientific contact
Name Harumasa Takano, MD, PhD
Address Anagawa 4-9-1, Inage-ku, Chiba City, Chiba 263-8555, Japan Japan
Telephone
E-mail
Affiliation National Institute of Radiological Sciences Molecular Imaging Center